Impact of periodontitis on chemokines in smokers

Clinical Oral Investigations

Volumn 19, Issue 5, 2015, Pages 979-986

  Haytural, O ^a   Yaman, D ^a   Ural, E C ^a   Kantarci, A ^b   Demirel, Korkud ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b FORSYTH INSTITUTE   (United States)

Author keywords

Chemokines; Chronic periodontitis; Gingival crevicular fluid; Immune response; Periodontal disease; Smoking

Indexed keywords

CHEMOKINE;

ADULT; CASE CONTROL STUDY; CHEMISTRY; CHRONIC PERIODONTITIS; FEMALE; GINGIVITIS; HUMAN; IMMUNOASSAY; MALE; METABOLISM; PERIODONTAL INDEX; PLAQUE INDEX; SMOKING;

ADULT; CASE-CONTROL STUDIES; CHEMOKINES; CHRONIC PERIODONTITIS; DENTAL PLAQUE INDEX; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; IMMUNOASSAY; MALE; PERIODONTAL INDEX; SMOKERS;

EID: 84929191286     PISSN: 14326981     EISSN: 14363771     Source Type: Journal    
DOI: 10.1007/s00784-014-1314-2     Document Type: Article

References (54)

1. Garlet GP, Avila-Campos MJ, Milanezi CM, Ferreira BR, Silva JS (2005) Actinobacillus actinomycetemcomitans-induced periodontal disease in mice: patterns of cytokine, chemokine, and chemokine receptor expression and leukocyte migration. Microbes Infect 7(4):738–747. doi:10.1016/j.micinf.2005.01.012
2. Silva TA, Garlet GP, Fukada SY, Silva JS, Cunha FQ (2007) Chemokines in oral inflammatory diseases: apical periodontitis and periodontal disease. J Dent Res 86(4):306–319
3. Graves D (2008) Cytokines that promote periodontal tissue destruction. J Periodontol 79(8 Suppl):1585–1591. doi:10.1902/jop.2008.080183
4. Bachmann MF, Kopf M, Marsland BJ (2006) Chemokines: more than just road signs. Nat Rev Immunol 6(2):159–164. doi:10.1038/nri1776
5. Baggiolini M (1998) Chemokines and leukocyte traffic. Nature 392(6676):565–568. doi:10.1038/33340
6. Kabashima H, Yoneda M, Nagata K, Hirofuji T, Maeda K (2002) The presence of chemokine (MCP-1, MIP-1alpha, MIP-1beta, IP-10, RANTES)-positive cells and chemokine receptor (CCR5, CXCR3)-positive cells in inflamed human gingival tissues. Cytokine 20(2):70–77
7. Jiang Y, Graves DT (1999) Periodontal pathogens stimulate CC-chemokine production by mononuclear and bone-derived cells. J Periodontol 70(12):1472–1478. doi:10.1902/jop.1999.70.12.1472
8. Fleetwood AJ, Dinh H, Cook AD, Hertzog PJ, Hamilton JA (2009) GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on type I interferon signaling. J Leukoc Biol 86(2):411–421. doi:10.1189/jlb.1108702
9. Niu J, Kolattukudy PE (2009) Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications. Clin Sci (Lond) 117(3):95–109. doi:10.1042/CS20080581
10. Koch AE, Kunkel SL, Harlow LA, Johnson B, Evanoff HL, Haines GK, Burdick MD, Pope RM, Strieter RM (1992) Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J Clin Invest 90(3):772–779. doi:10.1172/JCI115950
11. Graves DT (1999) The potential role of chemokines and inflammatory cytokines in periodontal disease progression. Clin Infect Dis 28(3):482–490. doi:10.1086/515178
12. Emingil G, Atilla G, Huseyinov A (2004) Gingival crevicular fluid monocyte chemoattractant protein-1 and RANTES levels in patients with generalized aggressive periodontitis. J Clin Periodontol 31(10):829–834. doi:10.1111/j.1600-051X.2004.00584.x
13. Kurtis B, Tuter G, Serdar M, Akdemir P, Uygur C, Firatli E, Bal B (2005) Gingival crevicular fluid levels of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha in patients with chronic and aggressive periodontitis. J Periodontol 76(11):1849–1855. doi:10.1902/jop.2005.76.11.1849
14. Cook DN (1996) The role of MIP-1 alpha in inflammation and hematopoiesis. J Leukoc Biol 59(1):61–66
15. Roth SJ, Carr MW, Springer TA (1995) C-C chemokines, but not the C-X-C chemokines interleukin-8 and interferon-gamma inducible protein-10, stimulate transendothelial chemotaxis of T lymphocytes. Eur J Immunol 25(12):3482–3488. doi:10.1002/eji.1830251241
16. Schall TJ, Bacon K, Camp RD, Kaspari JW, Goeddel DV (1993) Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes. J Exp Med 177(6):1821–1826
17. Taub DD, Conlon K, Lloyd AR, Oppenheim JJ, Kelvin DJ (1993) Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta. Science 260(5106):355–358
18. Garlet GP, Martins W Jr, Ferreira BR, Milanezi CM, Silva JS (2003) Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease. J Periodontal Res 38(2):210–217
19. Emingil G, Atilla G, Baskesen A, Berdeli A (2005) Gingival crevicular fluid EMAP-II, MIP-1alpha and MIP-1beta levels of patients with periodontal disease. J Clin Periodontol 32(8):880–885. doi:10.1111/j.1600-051X.2005.00780.x
20. Bischoff SC, Krieger M, Brunner T, Rot A, von Tscharner V, Baggiolini M, Dahinden CA (1993) RANTES and related chemokines activate human basophil granulocytes through different G protein-coupled receptors. Eur J Immunol 23(3):761–767. doi:10.1002/eji.1830230329
21. Emingil G, Gurkan A, Atilla G, Kantarci A (2011) Subantimicrobial-dose doxycycline and cytokine-chemokine levels in gingival crevicular fluid. J Periodontol 82(3):452–461. doi:10.1902/jop.2010.100036
22. Gemmell E, Carter CL, Seymour GJ (2001) Chemokines in human periodontal disease tissues. Clin Exp Immunol 125(1):134–141
23. Bergstrom J, Preber H (1994) Tobacco use as a risk factor. J Periodontol 65(5 Suppl):545–550. doi:10.1902/jop.1994.65.5s.545
24. Grossi SG, Genco RJ, Machtei EE, Ho AW, Koch G, Dunford R, Zambon JJ, Hausmann E (1995) Assessment of risk for periodontal disease. II. Risk indicators for alveolar bone loss. J Periodontol 66(1):23–29. doi:10.1902/jop.1995.66.1.23
25. Syrjala AM, Ylostalo P, Niskanen MC, Knuuttila ML (2003) Role of smoking and HbA1c level in periodontitis among insulin-dependent diabetic patients. J Clin Periodontol 30(10):871–875
26. Meisel P, Schwahn C, Gesch D, Bernhardt O, John U, Kocher T (2004) Dose-effect relation of smoking and the interleukin-1 gene polymorphism in periodontal disease. J Periodontol 75(2):236–242. doi:10.1902/jop.2004.75.2.236
27. Papapanou PN (1996) Periodontal diseases: epidemiology. Ann Periodontol 1(1):1–36. doi:10.1902/annals.1996.1.1.1
28. Rezavandi K, Palmer RM, Odell EW, Scott DA, Wilson RF (2002) Expression of ICAM-1 and E-selectin in gingival tissues of smokers and non-smokers with periodontitis. J Oral Pathol Med 31(1):59–64
29. Mirbod SM, Ahing SI, Pruthi VK (2001) Immunohistochemical study of vestibular gingival blood vessel density and internal circumference in smokers and non-smokers. J Periodontol 72(10):1318–1323. doi:10.1902/jop.2001.72.10.1318
30. Seow WK, Thong YH, Nelson RD, MacFarlane GD, Herzberg MC (1994) Nicotine-induced release of elastase and eicosanoids by human neutrophils. Inflammation 18(2):119–127
31. Haffajee AD, Socransky SS (2001) Relationship of cigarette smoking to the subgingival microbiota. J Clin Periodontol 28(5):377–388
32. van Winkelhoff AJ, Bosch-Tijhof CJ, Winkel EG, van der Reijden WA (2001) Smoking affects the subgingival microflora in periodontitis. J Periodontol 72(5):666–671. doi:10.1902/jop.2001.72.5.666
33. Gamal AY, Bayomy MM (2002) Effect of cigarette smoking on human PDL fibroblasts attachment to periodontally involved root surfaces in vitro. J Clin Periodontol 29(8):763–770
34. Ryder MI (2007) The influence of smoking on host responses in periodontal infections. Periodontol 2000 43:267–277. doi:10.1111/j.1600-0757.2006.00163.x
35. Walter C, Kaye EK, Dietrich T (2012) Active and passive smoking: assessment issues in periodontal research. Periodontol 2000 58(1):84–92. doi:10.1111/j.1600-0757.2011.00417.x
36. Warnakulasuriya S, Dietrich T, Bornstein MM, Casals Peidro E, Preshaw PM, Walter C, Wennstrom JL, Bergstrom J (2010) Oral health risks of tobacco use and effects of cessation. Int Dent J 60(1):7–30
37. Johnson JD, Houchens DP, Kluwe WM, Craig DK, Fisher GL (1990) Effects of mainstream and environmental tobacco smoke on the immune system in animals and humans: a review. Crit Rev Toxicol 20(5):369–395. doi:10.3109/10408449009089870
38. Loe H, Silness J (1963) Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 21:533–551
39. Lamster IB, Hartley LJ, Oshrain RL, Gordon JM (1985) Evaluation and modification of spectrophotometric procedures for analysis of lactate dehydrogenase, beta-glucuronidase and arylsulphatase in human gingival crevicular fluid collected with filter-paper strips. Arch Oral Biol 30(3):235–242
40. Gamonal J, Bascones A, Jorge O, Silva A (2000) Chemokine RANTES in gingival crevicular fluid of adult patients with periodontitis. J Clin Periodontol 27(9):675–681
41. Lamster IB, Oshrain RL, Fiorello LA, Celenti RS, Gordon JM (1988) A comparison of 4 methods of data presentation for lysosomal enzyme activity in gingival crevicular fluid. J Clin Periodontol 15(6):347–352
42. Lamster IB, Oshrain RL, Gordon JM (1986) Enzyme activity in human gingival crevicular fluid: considerations in data reporting based on analysis of individual crevicular sites. J Clin Periodontol 13(8):799–804
43. Griffiths GS, Wilton JM, Curtis MA (1997) Permeability of the gingival tissues to IgM during an experimental gingivitis study in man. Arch Oral Biol 42(2):129–136
44. Tymkiw KD, Thunell DH, Johnson GK, Joly S, Burnell KK, Cavanaugh JE, Brogden KA, Guthmiller JM (2011) Influence of smoking on gingival crevicular fluid cytokines in severe chronic periodontitis. J Clin Periodontol 38(3):219–228. doi:10.1111/j.1600-051X.2010.01684.x
45. Shimada Y, Tabeta K, Sugita N, Yoshie H (2013) Profiling biomarkers in gingival crevicular fluid using multiplex bead immunoassay. Arch Oral Biol 58(6):724–730. doi:10.1016/j.archoralbio.2012.11.012
46. Hanioka T, Takaya K, Matsumori Y, Matsuse R, Shizukuishi S (2000) Relationship of the substance P to indicators of host response in human gingival crevicular fluid. J Clin Periodontol 27(4):262–266
47. Lee E, Yang YH, Ho YP, Ho KY, Tsai CC (2003) Potential role of vascular endothelial growth factor, interleukin-8 and monocyte chemoattractant protein-1 in periodontal diseases. Kaohsiung J Med Sci 19(8):406–415. doi:10.1016/S1607-551X(09)70484-X
48. Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A (2000) Levels of interleukin-1 beta, -8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment. J Periodontol 71(10):1535–1545. doi:10.1902/jop.2000.71.10.1535
49. Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A (2001) Characterization of cellular infiltrate, detection of chemokine receptor CCR5 and interleukin-8 and RANTES chemokines in adult periodontitis. J Periodontal Res 36(3):194–203
50. Gemmell E, Seymour GJ (1998) Cytokine profiles of cells extracted from humans with periodontal diseases. J Dent Res 77(1):16–26
51. Anil S, Preethanath RS, Alasqah M, Mokeem SA, Anand PS (2013) Increased levels of serum and gingival crevicular fluid monocyte chemoattractant protein-1 in smokers with periodontitis. J Periodontol 84(9):e23–e28. doi:10.1902/jop.2013.120666
52. Pradeep AR, Daisy H, Hadge P (2009) Serum levels of monocyte chemoattractant protein-1 in periodontal health and disease. Cytokine 47(2):77–81. doi:10.1016/j.cyto.2009.05.012
53. Browne RW, Kantarci A, LaMonte MJ, Andrews CA, Hovey KM, Falkner KL, Cekici A, Stephens D, Genco RJ, Scannapieco FA, Van Dyke TE, Wactawski-Wende J (2013) Performance of multiplex cytokine assays in serum and saliva among community-dwelling postmenopausal women. PLoS One 8(4):e59498. doi:10.1371/journal.pone.0059498
54. Goodson JM, Kantarci A, Hartman ML, Denis GV, Stephens D, Hasturk H, Yaskell T, Vargas J, Wang X, Cugini M, Barake R, Alsmadi O, Al-Mutawa S, Ariga J, Soparkar P, Behbehani J, Behbehani K, Welty F (2014) Metabolic disease risk in children by salivary biomarker analysis. PLoS One 9(6):e98799. doi:10.1371/journal.pone.0098799